THANK YOU FOR SUBSCRIBING
The additional capital that Diagnostic Robotics raises will be used to hasten product development, go-to-market expansion, investments in sales and marketing, and other important hires across the company.
FREMONT, CA: "Diagnostic Robotics is using the most precise predictive models, leveraging nuanced definitions of risk and shifting focus away from purely risk-based targeting to clinically-actionable targeting to not only change how health plans approach their members, but to drastically improve member clinical care journeys," says Dr. Kira Radinsky CEO of Diagnostic Robotics.
Diagnostic Robotics is one of the top AI & Care Management solutions suppliers for healthcare plans and providers. Declared the completion of a $45M Series B fundraising round led by StageOne investors, with participation from Mayo Clinic, and as a result, became a Mayo Clinic Platform portfolio company. Along with other current investors, the Technion is the Israel Institute of Technology. Bradley Bloom, a strategic angel investor, and Berkshire Partners co-founder, also participated in this funding round.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
With AI, significant clients of Diagnostic Robotics, like Blue Cross & Blue Shield of Rhode Island, have implemented care management programs and enhanced patient outcomes and treatment pathways by focusing on accurately and effectively forecasting patient risk. Dr. Kira Radinsky served as the director of data science and chief scientist for eBay Israel before helping to co-found Diagnostic Robotics in her present capacity as CEO.
"We are incredibly excited to be partnering with Kira and the team as they expand and change the way health plans address risk, while helping to drive immensely improved care management for members." says Yossi Vinitski of StageOne Ventures.
Diagnostic Robotics creates prediction models that, among other things, minimize needless trips to the ER, deterioration of congestive heart failure, and severe mental illness. The business keeps engineering new models and platforms as part of its growing product lineup.
More in News